vs
Side-by-side financial comparison of IRONWOOD PHARMACEUTICALS INC (IRWD) and Orange County Bancorp, Inc. (OBT). Click either name above to swap in a different company.
IRONWOOD PHARMACEUTICALS INC is the larger business by last-quarter revenue ($47.7M vs $33.0M, roughly 1.4× Orange County Bancorp, Inc.). Orange County Bancorp, Inc. runs the higher net margin — 37.6% vs -4.8%, a 42.4% gap on every dollar of revenue. On growth, Orange County Bancorp, Inc. posted the faster year-over-year revenue change (20.6% vs -47.3%). IRONWOOD PHARMACEUTICALS INC produced more free cash flow last quarter ($74.6M vs $41.3M). Over the past eight quarters, Orange County Bancorp, Inc.'s revenue compounded faster (14.3% CAGR vs -20.2%).
Ironwood Pharmaceuticals, Inc. is a publicly traded pharmaceutical company. It was originally called Microbia, Inc.
Orange County Bancorp, Inc. is a Delaware-registered bank holding company operating mainly in New York, U.S. It offers a full range of retail and commercial banking services, including deposit accounts, loans and wealth management solutions, serving individual consumers, small and mid-sized corporate clients in its regional footprint.
IRWD vs OBT — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $47.7M | $33.0M |
| Net Profit | $-2.3M | $12.4M |
| Gross Margin | — | — |
| Operating Margin | 14.3% | 41.4% |
| Net Margin | -4.8% | 37.6% |
| Revenue YoY | -47.3% | 20.6% |
| Net Profit YoY | -200.9% | 73.5% |
| EPS (diluted) | $0.01 | $0.94 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $47.7M | $33.0M | ||
| Q3 25 | $122.1M | $33.7M | ||
| Q2 25 | $85.2M | $32.5M | ||
| Q1 25 | $41.1M | $28.0M | ||
| Q4 24 | $90.5M | $27.4M | ||
| Q3 24 | $91.6M | $27.1M | ||
| Q2 24 | $94.4M | $27.9M | ||
| Q1 24 | $74.9M | $25.3M |
| Q4 25 | $-2.3M | $12.4M | ||
| Q3 25 | $40.1M | $10.0M | ||
| Q2 25 | $23.6M | $10.5M | ||
| Q1 25 | $-37.4M | $8.7M | ||
| Q4 24 | $2.3M | $7.2M | ||
| Q3 24 | $3.6M | $3.2M | ||
| Q2 24 | $-860.0K | $8.2M | ||
| Q1 24 | $-4.2M | $9.3M |
| Q4 25 | 14.3% | 41.4% | ||
| Q3 25 | 61.8% | 38.6% | ||
| Q2 25 | 53.2% | 41.9% | ||
| Q1 25 | -70.7% | 40.3% | ||
| Q4 24 | 34.8% | 32.8% | ||
| Q3 24 | 28.0% | 14.8% | ||
| Q2 24 | 26.5% | 36.6% | ||
| Q1 24 | 14.7% | 45.9% |
| Q4 25 | -4.8% | 37.6% | ||
| Q3 25 | 32.8% | 29.7% | ||
| Q2 25 | 27.7% | 32.2% | ||
| Q1 25 | -90.9% | 31.1% | ||
| Q4 24 | 2.5% | 26.2% | ||
| Q3 24 | 4.0% | 11.8% | ||
| Q2 24 | -0.9% | 29.4% | ||
| Q1 24 | -5.6% | 36.7% |
| Q4 25 | $0.01 | $0.94 | ||
| Q3 25 | $0.23 | $0.75 | ||
| Q2 25 | $0.14 | $0.87 | ||
| Q1 25 | $-0.23 | $0.77 | ||
| Q4 24 | $0.03 | $0.64 | ||
| Q3 24 | $0.02 | $0.28 | ||
| Q2 24 | $-0.01 | $0.73 | ||
| Q1 24 | $-0.03 | $0.82 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $215.5M | — |
| Total DebtLower is stronger | — | — |
| Stockholders' EquityBook value | $-261.8M | $284.4M |
| Total Assets | $396.9M | $2.7B |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $215.5M | — | ||
| Q3 25 | $140.4M | — | ||
| Q2 25 | $92.9M | — | ||
| Q1 25 | $108.5M | — | ||
| Q4 24 | $88.6M | — | ||
| Q3 24 | $88.2M | — | ||
| Q2 24 | $105.5M | — | ||
| Q1 24 | $121.5M | — |
| Q4 25 | — | — | ||
| Q3 25 | $199.5M | — | ||
| Q2 25 | $199.3M | — | ||
| Q1 25 | $199.2M | — | ||
| Q4 24 | $199.0M | — | ||
| Q3 24 | $198.8M | — | ||
| Q2 24 | $198.6M | — | ||
| Q1 24 | $398.3M | — |
| Q4 25 | $-261.8M | $284.4M | ||
| Q3 25 | $-264.2M | $270.1M | ||
| Q2 25 | $-308.2M | $252.6M | ||
| Q1 25 | $-334.1M | $201.3M | ||
| Q4 24 | $-301.3M | $185.5M | ||
| Q3 24 | $-311.3M | $193.1M | ||
| Q2 24 | $-321.7M | $177.5M | ||
| Q1 24 | $-330.5M | $168.7M |
| Q4 25 | $396.9M | $2.7B | ||
| Q3 25 | $396.1M | $2.6B | ||
| Q2 25 | $342.9M | $2.6B | ||
| Q1 25 | $327.2M | $2.6B | ||
| Q4 24 | $350.9M | $2.5B | ||
| Q3 24 | $389.5M | $2.5B | ||
| Q2 24 | $395.6M | $2.5B | ||
| Q1 24 | $438.8M | $2.5B |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $74.6M | $43.8M |
| Free Cash FlowOCF − Capex | $74.6M | $41.3M |
| FCF MarginFCF / Revenue | 156.3% | 125.1% |
| Capex IntensityCapex / Revenue | 0.0% | 7.6% |
| Cash ConversionOCF / Net Profit | — | 3.53× |
| TTM Free Cash FlowTrailing 4 quarters | $127.0M | $69.6M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $74.6M | $43.8M | ||
| Q3 25 | $47.6M | $30.2M | ||
| Q2 25 | $-15.1M | $-5.0M | ||
| Q1 25 | $20.0M | $4.8M | ||
| Q4 24 | $15.2M | $34.6M | ||
| Q3 24 | $9.9M | $10.2M | ||
| Q2 24 | $33.5M | $9.3M | ||
| Q1 24 | $45.0M | $2.3M |
| Q4 25 | $74.6M | $41.3M | ||
| Q3 25 | $47.6M | $29.6M | ||
| Q2 25 | $-15.1M | $-5.7M | ||
| Q1 25 | $19.9M | $4.3M | ||
| Q4 24 | — | $32.9M | ||
| Q3 24 | $9.9M | $10.0M | ||
| Q2 24 | $33.4M | $9.2M | ||
| Q1 24 | $44.9M | $2.0M |
| Q4 25 | 156.3% | 125.1% | ||
| Q3 25 | 39.0% | 87.8% | ||
| Q2 25 | -17.7% | -17.5% | ||
| Q1 25 | 48.4% | 15.5% | ||
| Q4 24 | — | 120.0% | ||
| Q3 24 | 10.8% | 36.7% | ||
| Q2 24 | 35.4% | 32.8% | ||
| Q1 24 | 60.0% | 7.9% |
| Q4 25 | 0.0% | 7.6% | ||
| Q3 25 | 0.0% | 1.8% | ||
| Q2 25 | 0.0% | 2.3% | ||
| Q1 25 | 0.1% | 1.8% | ||
| Q4 24 | 0.0% | 6.3% | ||
| Q3 24 | 0.0% | 1.1% | ||
| Q2 24 | 0.1% | 0.4% | ||
| Q1 24 | 0.1% | 1.0% |
| Q4 25 | — | 3.53× | ||
| Q3 25 | 1.19× | 3.01× | ||
| Q2 25 | -0.64× | -0.47× | ||
| Q1 25 | — | 0.56× | ||
| Q4 24 | 6.74× | 4.83× | ||
| Q3 24 | 2.71× | 3.19× | ||
| Q2 24 | — | 1.13× | ||
| Q1 24 | — | 0.24× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
